Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole + Methylphenidate in Pediatric BD and ADHD
NCT00305370Phase 4Completed
- Sponsor
- Universidade Federal do Rio Grande do Sul
- Start
- Aug 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Universidade Federal do Rio Grande do Sul. Primary endpoints: Swanson, Nolan, and Pelham-IV Questionnaire, Young Mania Rating Scale and 1 more. Started Aug 2005; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00305370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305370.